1. Home
  2. TSHA vs BBW Comparison

TSHA vs BBW Comparison

Compare TSHA & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • BBW
  • Stock Information
  • Founded
  • TSHA 2019
  • BBW 1997
  • Country
  • TSHA United States
  • BBW United States
  • Employees
  • TSHA N/A
  • BBW N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • BBW Recreational Games/Products/Toys
  • Sector
  • TSHA Health Care
  • BBW Consumer Discretionary
  • Exchange
  • TSHA Nasdaq
  • BBW Nasdaq
  • Market Cap
  • TSHA 728.4M
  • BBW 672.6M
  • IPO Year
  • TSHA 2020
  • BBW 2004
  • Fundamental
  • Price
  • TSHA $2.94
  • BBW $55.49
  • Analyst Decision
  • TSHA Strong Buy
  • BBW Strong Buy
  • Analyst Count
  • TSHA 7
  • BBW 4
  • Target Price
  • TSHA $8.71
  • BBW $55.75
  • AVG Volume (30 Days)
  • TSHA 2.7M
  • BBW 208.4K
  • Earning Date
  • TSHA 08-12-2025
  • BBW 08-28-2025
  • Dividend Yield
  • TSHA N/A
  • BBW 1.58%
  • EPS Growth
  • TSHA N/A
  • BBW 19.03
  • EPS
  • TSHA N/A
  • BBW 4.15
  • Revenue
  • TSHA $8,098,000.00
  • BBW $510,069,000.00
  • Revenue This Year
  • TSHA N/A
  • BBW $6.10
  • Revenue Next Year
  • TSHA N/A
  • BBW $3.90
  • P/E Ratio
  • TSHA N/A
  • BBW $13.39
  • Revenue Growth
  • TSHA N/A
  • BBW 6.09
  • 52 Week Low
  • TSHA $1.05
  • BBW $26.67
  • 52 Week High
  • TSHA $3.31
  • BBW $56.99
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 62.34
  • BBW 60.97
  • Support Level
  • TSHA $2.69
  • BBW $49.26
  • Resistance Level
  • TSHA $3.12
  • BBW $56.99
  • Average True Range (ATR)
  • TSHA 0.17
  • BBW 1.89
  • MACD
  • TSHA 0.02
  • BBW 0.50
  • Stochastic Oscillator
  • TSHA 68.97
  • BBW 81.82

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

Share on Social Networks: